TRIM29 Recombinant Antibody, FITC Conjugated
Product Specifications
Background
Plays a crucial role in the regulation of macrophage activation in response to viral or bacterial infections within the respiratory tract. Mechanistically, TRIM29 interacts with IKBKG/NEMO in the lysosome where it induces its 'Lys-48' ubiquitination and subsequent degradation. In turn, the expression of type I interferons and the production of pro-inflammatory cytokines are inhibited. Additionally, induces the 'Lys-48' ubiquitination of STING1 in a similar way, leading to its degradation.
Synonyms
ATDC; TRIM29.
Gene ID
23650
Swiss Prot
Q14134
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
TRIM29
Clonality
Recombinant
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human TRIM29
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
23650
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1355316-01 0.02 mg (E-Coli)
Recombinant Xanthomonas campestris pv. vesicatoria Glutamate 5-kinase (proB)
Ask
View Details 
MBS1355316-02 0.02 mg (Yeast)
Recombinant Xanthomonas campestris pv. vesicatoria Glutamate 5-kinase (proB)
Ask
View Details 
MBS1355316-03 0.1 mg (E-Coli)
Recombinant Xanthomonas campestris pv. vesicatoria Glutamate 5-kinase (proB)
Ask
View Details